Nanogen, Inc. (Nasdaq: NGEN), developer of molecular and rapid diagnostic products, announced today that it has signed an end user license agreement (EULA) with Quest Diagnostics for use of the Company’s proprietary MGB Probe technology in human in vitro diagnostic testing. Under the licensing agreement, Quest Diagnostics will have rights to use and sell products […]
CUPERTINO, Calif.–BioImagene, the leading provider of innovative digital pathology solutions, today announced the appointment of Doug Sweet as Vice President of Sales and Marketing. Mr. Sweet has more than 30 years of experience in business development, marketing and sales in the Diagnostic Industry – Clinical and Anatomic Pathology, Life Science and BioPharma. Dr. Ajit Singh, […]
SADDLE RIVER, N.J. & SAN DIEGO–PDI, Inc. (NASDAQ:PDII), and Sequenom Center for Molecular Medicine, LLC (SCMM), a wholly owned subsidiary of Sequenom, Inc. (NASDAQ:SQNM) announced today that PDI has been selected to provide the sales infrastructure to launch and commercialize SCMM’s noninvasive prenatal genetic screening tests based on its SEQureDx™ technology. Under the direction of […]
Integration of IT and healthcare advanced through multi-year agreement HP and Partners HealthCare today announced the extension of a successful five-year, multi-million dollar agreement to develop software and implement hardware and services supporting Partners’ efforts to accelerate clinical genomics and advance personalized medicine. This phase of the collaboration focuses on extending Partners’ technology infrastructure, especially […]
Lab21 Ltd has today announced that it has purchased the majority shareholding of Biotec Laboratories Ltd, a clinical diagnostic company with particular emphasis on infectious diseases, most notably tuberculosis (TB). As part of the sale, Lab21 also acquires Biotec’s South African subsidiary, Biotec Laboratories SA which is a joint venture with the Cape Biotech Trust. […]
Improved TB Testing With Seeplex(R) MTB ACE Detection Promises to Help Eradicate a Disease Threatening Public Health Worldwide ROCKVILLE, MD – Early detection and treatment of tuberculosis (TB) is an international health care priority, as rapidly migrating populations in a globalized economy ensure the continuation of this highly treatable disease. TB is highly contagious and […]
SAN DIEGO, Calif., March 2 — Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it is borrowing $170 million under a newly issued line of credit to finance its pending acquisition of Tepnel Life Sciences PLC and other general corporate activities, including its existing share repurchase program. The Company will pay interest on the one-year, $180 […]
– Expands Beckman Coulter’s Worldwide Position in Clinical Chemistry – Complementary Market Positions and Product Portfolios in Chemistry and Automation Broaden Global Opportunity, Increase Customer Choice – Penetration of Beckman Coulter’s Immunoassay Products into Olympus’ Installed Chemistry Base Supports Continued Above-Market Growth – Transaction Expected to be Accretive to Non-GAAP Earnings Per Share in 2010 […]
LOS ANGELES–Response Genetics, Inc. (Nasdaq:RGDX) announced today that it has entered into a purchase agreement with certain affiliated funds of Special Situations Funds to raise $2 million from the private placement of 2,000,000 newly issued shares of its common stock, at a purchase price of $1.00 per share. The closing of the sale of the […]
Data Demonstrates that Test Can Identify Cancer Early Through Analysis of Blood MUKILTEO, Wash., Feb. 26, 2009 — CombiMatrix Corporation (NasdaqGM:CBMX – News) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it can non-invasively screen for the early detection of cancer. The study focused on prostate, colon, ovarian, breast, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
